個人化細胞治療市場按細胞類型、治療領域、最終用戶和地區分類

2025 年全球個人化細胞治療市場規模估計為 175.9 億美元，預計到 2032 年將達到 820.8 億美元，2025 年至 2032 年的複合年成長率為 24.6%。

數字。 2025 年個人化細胞治療市場佔有率（按地區分類）

全球個人化細胞治療市場的成長是由主要企業加大研發投入來開發先進的細胞療法來治療各種慢性和危及生命的疾病所推動的。個人化細胞療法涉及從患者自身分離和操縱細胞以產生治療效果。這一新領域可望開發出治療癌症、神經系統疾病、心血管疾病等的治療方法。基因組學、細胞生物學和工程技術的進步正在幫助科學家更好地了解細胞在健康和疾病狀態下的功能。隨著越來越多的細胞治療產品獲得監管部門核准並在臨床中採用，市場可能會成長。

市場動態

全球個人化細胞治療市場的成長受到多種因素的推動，例如癌症和其他無法治癒的疾病盛行率上升、老齡化人口增加且易患慢性病、再生醫學的應用日益廣泛、細胞治療的應用不斷擴大、生物技術的進步以及對基於細胞的研究的大量投資。然而，高昂的治療成本、較長的開發週期以及臨床試驗的監管障礙可能會阻礙市場成長。持續研究 iPSC（誘導性多功能幹細胞）技術、採用 CAR-T 細胞療法、同種異體細胞療法的研究和開發以及積累細胞療法療效的證據可以為相關人員提供有利可圖的機會。

研究的主要特點

• 本報告對全球個人化細胞治療市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
• 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 全球個人化細胞治療市場主要企業根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行分析。
• 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球個人化細胞療法市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員將透過全球個人化細胞治療市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章 全球個人化細胞治療市場-冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球個人化細胞治療市場（按細胞類型分類）（十億美元）

• 介紹
• 淋巴球
• 間質幹細胞
• 造血幹細胞
• 其他

6. 2020 年至 2032 年按治療領域分類的全球個人化細胞治療市場（十億美元）

• 介紹
• 心血管疾病
• 神經系統疾病
• 發炎性疾病
• 糖尿病
• 癌症

7. 2020 年至 2032 年全球個人化細胞治療市場（按最終用戶分類）（十億美元）

• 介紹
• 醫院
• 居家醫療
• 專科門診
• 其他

8. 2020 年至 2032 年全球個人化細胞治療市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara BIoTherapeutics, Inc.
  • Holostem Terapie Avanzate Srl
• 興衰
• 一致的機會地圖

第10章參考文獻與調查方法

• 參考
• 調查方法

Global Personalized Cell Therapy Market is estimated to be valued at USD 17.59 Bn in 2025 and is expected to reach USD 82.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 24.6% from 2025 to 2032.

Figure. Personalized Cell Therapy Market Share (%), By Region 2025

Global personalized cell therapy market growth is driven by increasing R&D investments by key players in developing advanced cell therapies for treating various chronic and life-threatening diseases. Personalized cell therapy involves isolation and manipulation of cells from patient's own body to produce therapeutic effects. This emerging field holds promise for developing curative treatments for cancer, neurological disorders, cardiovascular diseases and others. With advancements in genomics, cell biology and engineering technologies, scientists are gaining deeper understanding of how cells function in healthy and diseased conditions, thus, allowing them to exploit cells' therapeutic potential in a personalized way. The market can witness growth as more cell therapy products receive regulatory approvals and get adopted in clinical practice.

Market Dynamics:

Global personalized cell therapy market growth is driven by several factors such as rising prevalence of cancer and other incurable diseases, growing geriatric population susceptible to chronic illnesses, increasing adoption of regenerative medicines, expanding applications of cell therapies, advances in biotechnology, and heavy investments in cell-based research. However, high treatment costs, long development cycles, and regulatory hurdles surrounding clinical trials can hamper the market growth. Ongoing research on iPSC (induced pluripotent stem cells) technology, adoption of CAR T-cell therapies, development of allogenic cell therapies, growing body of evidence on effectiveness of cell therapies can offer lucrative opportunities for stakeholders.

Key Features of the Study:

• This report provides in-depth analysis of the global personalized cell therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global personalized cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Juno Therapeutics, Cellectis, Bellicum Pharmaceuticals, Vericel, Pharmicell, Pluristem Therapeutics, BioLineRx, Mesoblast.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global personalized cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized cell therapy market.

Detailed Segmentation-

• By Cell Type
  • Lymphocytes
  • Mesenchymal Stem Cell
  • Hematopoietic Stem Cell
  • Others
• By Therapeutic Area
  • Cardiovascular Diseases
  • Neurological Disorders
  • Inflammatory Diseases
  • Diabetes
• By End Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Cell Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Personalized Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Personalized Cell Therapy Market, By Cell Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Lymphocytes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mesenchymal Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematopoietic Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Personalized Cell Therapy Market, By Therapeutic Area, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Personalized Cell Therapy Market, By End Users, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Personalized Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Novartis AG
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Gilead Sciences, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"